Jeff Yass’s TuHURA Biosciences HURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$224K Buy
106,679
+93,329
+699% +$203K ﹤0.01% 11661
2026
Q2
$31.2K Sell
13,350
-17,497
-57% -$40.8K ﹤0.01% 12950
2026
Q1
$55.2K Buy
+30,847
New +$37.8K ﹤0.01% 12611
2025
Q3
– Sell
-33,599
Closed -$74.9K – 14236
2025
Q2
$74.9K Buy
33,599
+19,801
+144% +$66.9K ﹤0.01% 11948
2025
Q1
$44.6K Buy
+13,798
New +$50.9K ﹤0.01% 11899
2024
Q4
– Sell
-3,649
Closed -$24.9K – 13464
2024
Q3
$24.9K Buy
3,649
+527
+17% +$3.92K ﹤0.01% 11579
2024
Q2
$29.5K Buy
3,122
+242
+8% +$1.51K ﹤0.01% 11574
2024
Q1
$10.5K Buy
+2,880
New +$11.6K ﹤0.01% 11903
2023
Q2
– Sell
-305
Closed -$39.2K – 13335
2023
Q1
$39.2K Buy
+305
New +$58.8K ﹤0.01% 11803
2022
Q1
– Sell
-18
Closed -$16K – 14140
2021
Q4
$16K Buy
+18
New +$24.3K ﹤0.01% 12869
2020
Q2
– Sell
-26
Closed -$17K – 11087
2020
Q1
$17K Buy
+26
New +$24.2K ﹤0.01% 9971
2017
Q4
– Sell
-21
Closed -$306K – 10025
2017
Q3
$306K Buy
+21
New +$575K ﹤0.01% 7353

Other funds holding HURA

Jeff Yass's HURA Position: Q3 2026 in Review

Jeff Yass increased its TuHURA Biosciences (HURA) stake by 699% in Q3 2026, buying an estimated $203K and bringing the position to 106,679 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #11661.

Jeff Yass first reported a position in HURA in Q3 2017 and has held it in 12 quarters since. The position peaked at $306K in Q3 2017. 76 funds tracked by Wall St. Rank hold HURA as of Q3 2026.

  • Jeff Yass held 106,679 shares of TuHURA Biosciences worth $224K as of Q3 2026.
  • Jeff Yass bought 93,329 TuHURA Biosciences shares in Q3 2026, an estimated $203K.
  • TuHURA Biosciences made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11661 holding.
  • Jeff Yass first reported a position in TuHURA Biosciences in Q3 2017 and has held it in 12 quarters since.
  • Jeff Yass's TuHURA Biosciences position peaked at $306K in Q3 2017.
  • 76 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.